Enzymatica AB, a Swedish healthcare company, reports strong sales growth but struggles with financial losses and negative cash flow, raising concerns about its sustainability and future prospects.

Enzymatica AB, a specialty research and development company, is facing leadership turmoil with the departure of its CFO and CEO, amid financial uncertainty and a significant drop in its stock price.

Enzymatica AB, a Swedish health care company, is undergoing a leadership shake-up with CEO Claus Egstrand stepping down, amidst plans for international expansion and a volatile financial year.